Longeveron Inc. (LGVN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.6800 |
| Open | 1.6700 |
| Bid | 1.6700 x 100 |
| Ask | 1.7000 x 100 |
| Day's range | 1.6500 - 1.7300 |
| 52-week range | 1.6000 - 40.0000 |
| Volume | |
| Avg. volume | 2,186,745 |
| Market cap | 10.629M |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)
Longeveron Inc (NASDAQ:LGVN), a biotechnology company specializing in the development of cellular therapies for aging-related and life-threatening conditions, has reported an insider purchase by a high-level executive.
- Simply Wall St.
Longeveron Full Year 2023 Earnings: EPS Misses Expectations
Longeveron ( NASDAQ:LGVN ) Full Year 2023 Results Key Financial Results Net loss: US$22.2m (loss widened by 18% from FY...
- Insider Monkey
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript February 27, 2024 Longeveron Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. FDS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, good afternoon, and […]
© 2024 Yahoo. All rights reserved.